NCI-H810Homo sapiens (Human)Cancer cell line

Also known as: NCIH810, H-810, H810

🤖 AI SummaryBased on 9 publications

Quick Overview

Human lung cancer cell line with potential for drug sensitivity studies.

Detailed Summary

The NCI-H810 cell line is a human lung cancer cell line derived from a non-small cell lung cancer (NSCLC) patient. It is part of a large panel of cancer cell lines used in research to study genetic and molecular characteristics of cancer. This cell line has been utilized in studies examining the role of RB-related genes and their mutations in cancer progression. Additionally, it has been included in comprehensive genomic and transcriptomic analyses to identify potential therapeutic targets and drug sensitivities. The cell line is available in various databases, including the Cancer Cell Line Encyclopedia (CCLE) and the Catalogue of Somatic Mutations in Cancer (COSMIC), providing researchers with valuable resources for molecular and pharmacological studies.

Research Applications

Genomic and transcriptomic analysisDrug sensitivity studiesRB-related gene mutation analysisCancer biology research

Key Characteristics

Expresses RB-related genesUsed in large-scale cancer cell line panelsAvailable in public databases for research
Generated on 6/17/2025

Basic Information

Database IDCVCL_1590
SpeciesHomo sapiens (Human)
Tissue SourceLung[UBERON:UBERON_0002048]

Donor Information

Age51
Age CategoryAdult
SexMale
Raceblack_or_african_american

Disease Information

DiseaseLung large cell carcinoma
LineageLung
SubtypeLarge Cell Lung Carcinoma
OncoTree CodeLCLC

DepMap Information

Source TypeATCC
Source IDACH-000789_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Glu294Ter (c.880G>T)Unspecified-PubMed=12872257
MutationSimpleDDR2p.Asn373del (c.1117_1119del)Heterozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10
D13S317
12,13
D16S539
9
D18S51
12,18
D19S433
13,14
D21S11
29
D2S1338
22
D3S1358
17
D5S818
11
D7S820
10
D8S1179
11,14
FGA
25,26
Penta D
2.2,10
Penta E
11
TH01
7,9
TPOX
10,11
vWA
15,16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

From clinical specimens to human cancer preclinical models -- a journey the NCI-cell line database-25 years later.

Aldige C.R., Wistuba I.I., Minna J.D.

J. Cell. Biochem. 121:3986-3999(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.

Modi S., Kubo A., Oie H.K., Coxon A.B., Rehmatulla A., Kaye F.J.

Oncogene 19:4632-4639(2000).

NCI-Navy Medical Oncology Branch cell line data base.";

Carney D.N., Minna J.D., Mulshine J.L.

J. Cell. Biochem. Suppl. 24:32-91(1996).

Neuromedin B is present in lung cancer cell lines.";

Giaccone G., Battey J., Gazdar A.F., Oie H.K., Draoui M., Moody T.W.

Cancer Res. 52:2732s-2736s(1992).

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

Gazdar A.F.

Oncogene 7:171-180(1992).

Web Resources